Brooks to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Summary

Brooks Automation (Nasdaq: BRKS) announced its participation in two virtual investor conferences: the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 17, 2021, and the Needham 2nd Annual SemiCap and EDA 1x1 Conference on August 24, 2021. This follows Brooks' plans to separate into two independent companies focused on Life Sciences and Semiconductor Solutions by the end of 2021. Brooks operates globally in North America, Europe, and Asia, providing advanced solutions for pharmaceutical and semiconductor industries.

CHELMSFORD, Mass., Aug. 11, 2021 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in two upcoming virtual investor conferences:

• 6^th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 17, 2021
• Needham Virtual 2^nd Annual SemiCap and EDA 1x1 Conference on August 24, 2021

About Brooks Automation
Brooks (Nasdaq: BRKS) operates two, global, market-leading businesses, Life Sciences and Semiconductor Solutions, each with its own distinct area of focus and expertise.  The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.  Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services.  With over 40 years as a partner to the semiconductor manufacturing industry, Brooks' Semiconductor Solutions business provides industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers as well as collaborative robotics and automation capabilities for multi-market applications. 

On May 10, 2021, Brooks announced its plans to separate into two, independent publicly traded companies by establishing a standalone life sciences company, comprised of the Life Sciences business and a standalone automation company, comprised of the Semiconductor Solutions business. The transaction is expected to be completed by the end of calendar year 2021.

Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, visit www.brooks.com.

INVESTOR CONTACTS:

Sara Silverman
Director, Investor Relations
Brooks Automation
978.262.2635
sara.silverman@brooks.com

Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/brooks-to-participate-in-upcoming-virtual-investor-conferences-301353541.html

SOURCE Brooks Automation

FAQ

What are the dates for Brooks Automation's upcoming investor conferences?

Brooks Automation will participate in two investor conferences: the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 17, 2021, and the Needham 2nd Annual SemiCap and EDA 1x1 Conference on August 24, 2021.

What is the significance of Brooks Automation's upcoming virtual conferences?

The conferences allow Brooks Automation to engage with investors and showcase its business strategies, especially the upcoming separation into two independent companies.

What are the two business segments of Brooks Automation?

Brooks Automation operates two main business segments: Life Sciences and Semiconductor Solutions.

When is Brooks Automation expected to complete its corporate separation?

Brooks Automation plans to complete the separation into two independent companies by the end of calendar year 2021.

Where is Brooks Automation headquartered?

Brooks Automation is headquartered in Chelmsford, Massachusetts.